Get the Stockscreener App
13.77
6.21%
0.805
After Hours:
13.77
0.005
+0.04%
Daxor Corporation stock is traded at $13.77, with a volume of 27,384.
It is up +6.21% in the last 24 hours and up +25.14% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$12.96
Open:
$12.87
24h Volume:
27,384
Relative Volume:
0.99
Market Cap:
$66.58M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
45.84
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+13.28%
1M Performance:
+25.14%
6M Performance:
+69.52%
1Y Performance:
+59.13%
1-Day Range:
$12.19
$14.00
1-Week Range:
$11.70
$14.00
52-Week Range:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.77 | 64.60M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Daxor Corporation's BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients - Quiver Quantitative
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA - GlobeNewswire
Zero Hospital Readmissions: Daxor's New Blood Volume Tech Shows Perfect Results in Heart Failure Study - Stock Titan
Technical analysis overview for Daxor Corporation stock2025 Performance Recap & Detailed Earnings Play Strategies - newser.com
Can Daxor Corporation (DX5) stock retain market dominanceJuly 2025 Trade Ideas & Verified Short-Term Trading Plans - newser.com
What technical patterns form on Daxor Corporation (DX5) stock chartsEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
How to manage a losing position in Daxor CorporationWeekly Stock Report & High Return Trade Guides - newser.com
Daxor (NASDAQ:DXR) Trading 7.6% Higher – What’s Next? - Defense World
Comparing Daxor (NASDAQ:DXR) & LifeStance Health Group (NASDAQ:LFST) - Defense World
Can Daxor Corporation recover in the next quarter2025 Investor Takeaways & Weekly Top Gainers Alerts - newser.com
Can Oswal Agro Mills Limited Deliver Growth Even in a Bearish MarketMarket Sentiment Shifts & Low Risk Trading Alerts - earlytimes.in
Is Daxor Corporation meeting your algorithmic filter criteriaM&A Rumor & Consistent Growth Stock Picks - newser.com
What drives Daxor Corporation stock priceTechnology Stock Trends & Follow Top Performers in the Community - earlytimes.in
What analysts say about Daxor Corporation stockPrice Action Analysis & Double Or Triple Wealth - earlytimes.in
Historical volatility pattern of Daxor Corporation visualizedJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Will Daxor Corporation stock rally after Fed decisionsEarnings Summary Report & Community Trade Idea Sharing - newser.com
Published on: 2025-09-26 14:13:58 - newser.com
Daxor to showcase new FDA-cleared blood volume analyzer at HFSA meeting - Investing.com Nigeria
Daxor to showcase new FDA-cleared blood volume analyzer at HFSA meeting By Investing.com - Investing.com South Africa
Daxor unveils next-gen BVA analyzer at HFSA annual meeting - TipRanks
Daxor (DXR) Showcases Next-Gen Blood Volume Analyzer at Key Medi - GuruFocus
Daxor Corporation to Showcase Next-Generation Blood Volume Analyzer at HFSA Annual Scientific Meeting, Highlighting New Clinical Data for Improved Heart Failure Management - Quiver Quantitative
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting - GlobeNewswire
3X Faster Blood Testing: Daxor's Revolutionary FDA-Cleared Heart Failure Analyzer Changes Patient Care - Stock Titan
Daxor Corporation stock momentum explainedTrade Risk Report & Target Return Focused Stock Picks - newser.com
The Pennant Group (NASDAQ:PNTG) vs. Daxor (NASDAQ:DXR) Head to Head Analysis - Defense World
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Tools to assess Daxor Corporation’s risk profile2025 Technical Overview & Verified Trade Idea Suggestions - newser.com
Quantitative breakdown of Daxor Corporation recent moveCPI Data & Weekly Setup with High ROI Potential - newser.com
Update Recap: What is the target price for Daxor Corporation stock2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):